HCLDR Moderator(@hcldr) 's Twitter Profile Photo

Time for T2: How can healthcare’s last mile ever be cleared of all bottlenecks? What access issues can be cleared with the least difficulty?

Time for T2: How can healthcare’s last mile ever be cleared of all bottlenecks? What access issues can be cleared with the least difficulty?

#hcldr
account_circle
Allison Rosen, MS(@ARosen380) 's Twitter Profile Photo

Anxiously awaiting to kickoff. I am excited to be attending as a part of the AACR Scientist<->Survivor Program. Would love to connect with atendees. Topics I am most interested in are: , , &

Anxiously awaiting #AACR21 to kickoff. I am excited to be attending as a part of the AACR Scientist<->Survivor Program. Would love to connect with atendees. Topics I am most interested in are: #colorectalcancer, #immunotherapy, #clincialtrials #prevention & #survivorship #AACRSSP
account_circle
e-INS(@INSeuro) 's Twitter Profile Photo

Take advantage of the Early Bird registration discount for e-INS 2023. 📢

Be at the forefront of the field of neuromodulation, witnessing breakthroughs firsthand.
📅 Register before June 12 and save up to 220 EUR!

account_circle
The Lancet Haematology(@TheLancetHaem) 's Twitter Profile Photo

NEW: Adolescents (≥15 years) treated on Children’s Oncology Group Hodgkin lymphoma trials had worse outcomes than children (<15 years), highlighting the need for prospective studies to examine tumour biology & to test novel therapies across the age spectrum thelancet.com/journals/lanha…

NEW: Adolescents (≥15 years) treated on @COGorg Hodgkin lymphoma trials had worse outcomes than children (<15 years), highlighting the need for prospective studies to examine tumour biology & to test novel therapies across the age spectrum #lymsm #pedonc thelancet.com/journals/lanha…
account_circle
Dr. Monica M. Bertagnolli(@NCIDirector) 's Twitter Profile Photo

One benefit of is that it enables remote informed consent.

We anticipate that this should help make it easier for more people to participate in – including underserved populations.

account_circle
Darko Medin(@MedinDarko) 's Twitter Profile Photo

Innovative Trials designs, Statistics and Data Science perspectives are among most important aspects of todays Biomedical and Pharmaceutical industries. These will be the topics in my upcoming Newsletter.

stats esearch

Innovative Trials designs, Statistics and Data Science perspectives are among most important aspects of todays Biomedical and Pharmaceutical industries. These will be the topics in my upcoming Newsletter.

#DataScience #clincialtrials #r #rstats #statistics #biomedicine #research
account_circle
The GOG Foundation Inc.(@GOG) 's Twitter Profile Photo

Congratulations Dr. Marilyn Huang, recipient of the GOG Foundation, Inc. New Investigator Award. For more information on this award and to view all recipients, visit ow.ly/X2ZN50Duxzn

Congratulations Dr. Marilyn Huang, recipient of the GOG Foundation, Inc. New Investigator Award.  For more information on this award and to view all recipients, visit ow.ly/X2ZN50Duxzn
#GOGF #gogfoundation #clincialtrials #gyncancers
account_circle
ACS CAN Kentucky(@ACSCANKY) 's Twitter Profile Photo

Don't miss this month's coffee club discussing and featuring speakers like Daniel Flora MD, PharmD, @dougfloraMD of St. Elizabeth, and more. You won't want to miss this! Join us for Coffee Club by registering at fightcancer.org/actions/acs-ca….

Don't miss this month's coffee club discussing #cancercare and #clincialtrials featuring speakers like @dbfloramd, @dougfloramd of @StElizabethNKY, and more. You won't want to miss this! Join us for Coffee Club by registering at fightcancer.org/actions/acs-ca….
account_circle
Bliq Photonics(@BliqPhotonics) 's Twitter Profile Photo

The laboratory of Martin Lévesque at the CERVO Research Center has chosen to benefit from the advantages of Bliq’s Bessel system in their exploration of circuit development from embryonic to adult stages 🐁

NEW case study 👉 buff.ly/3BP3vkX

The laboratory of Martin Lévesque at the CERVO Research Center has chosen to benefit from the advantages of Bliq’s Bessel #lightsheet system in their exploration of #mousedopaminergic circuit development from embryonic to adult stages 🐁

NEW case study 👉 buff.ly/3BP3vkX
account_circle
National Retail Federation(@NRFnews) 's Twitter Profile Photo

💻 Conversations at will converge on the ideas shaping the future of the industry including omnichannel technologies and strategies, automation, innovation, next-gen customer experiences, hyper-personalization, CRM and more. nrf.com/blog/plan-futu…

account_circle
STRESS-L Trial(@StressLTrial) 's Twitter Profile Photo

Welcome back Queen Elizabeth, Heartlands UHB Research and King's College King's College NHS who have restarted recruitment to STRESS-L today! We look forward to working with you again to further our understanding of septic shock. Tony Whitehouse

account_circle
Erin Moriarty Wade(@EMoriartyWade) 's Twitter Profile Photo

T2. @mytomorrows uses patient navigators to help reduce barriers and improve access to . The patient navigators, who speak seven languages, are have medical backgrounds and can explain complex medical concepts to patients. mytomorrows.com/en/blog/patien…

account_circle
QMENTA(@QMENTA_Inc) 's Twitter Profile Photo

Unlock the power of data. Check out our new website to learn about our expert, customized solutions that increase the value and usability of unstructured data. bit.ly/3fX6mwZ

Unlock the power of #neuroimaging data. Check out our new website to learn about our expert, customized solutions that increase the value and usability of unstructured data. bit.ly/3fX6mwZ #neurology #research #radiology #clincialtrials #aialgorithms
account_circle
Dr. Allyson Ocean(@drallysonocean) 's Twitter Profile Photo

We need to engage religious leaders and community leaders to help present information about who’s at risk for and how to find treatment and . People need to learn from voices they trust.

account_circle
Biosplice Therapeutics(@biosplice) 's Twitter Profile Photo

Aaron J. Scott MD with @Biosplice CMO, Dr. Beaupre before presenting novel data at describing preliminary evidence of clinical activity from phase I and Ib of the CLK/DYRK inhibitor cirtuvivint in subjects with advanced solid tumors. Link: oncologypro.esmo.org/meeting-resour…

@ajscott40 with @Biosplice CMO, Dr. Beaupre before presenting novel data at #ESMO22 describing preliminary evidence of clinical activity from phase I and Ib #clincialtrials of the CLK/DYRK inhibitor cirtuvivint in subjects with advanced solid tumors. Link: oncologypro.esmo.org/meeting-resour…
account_circle